{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:11:26Z","timestamp":1792185086189,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AR077869-01"],"award-info":[{"award-number":["1R01AR077869-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bone.2023.116723","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T12:02:42Z","timestamp":1677585762000},"page":"116723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Autosomal dominant osteopetrosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Lynda E.","family":"Polgreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Imel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2023.116723_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/8756-3282(88)90021-X","article-title":"Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis","volume":"9","author":"Bollerslev","year":"1988","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116723_bb0010","first-page":"365","article-title":"Rntgenbilder einer seltenen knochenkrankung","volume":"51","author":"Albers-Schonberg","year":"1904","journal-title":"Munch. Med. Wochenschr."},{"key":"10.1016\/j.bone.2023.116723_bb0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/514844","article-title":"Localization of a gene for autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease) to chromosome 1p21","volume":"61","author":"Van Hul","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2023.116723_bb0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1359\/jbmr.2002.17.6.1111","article-title":"Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13","volume":"17","author":"Van Hul","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116723_bb0025","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and Management of Osteopetrosis: consensus guidelines from the osteopetrosis working group","author":"Wu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116723_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajmg.a.30490","article-title":"Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations","volume":"133A","author":"Campos-Xavier","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2023.116723_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116723_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116723_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1227\/00006123-198810000-00011","article-title":"Optic nerve decompression for osteopetrosis in early childhood","volume":"23","author":"Haines","year":"1988","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bone.2023.116723_bb0050","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ajmg.a.32253","article-title":"The erlenmeyer flask bone deformity in the skeletal dysplasias","volume":"149A","author":"Faden","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2023.116723_bb0055","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/jbmr.3715","article-title":"Interferon gamma-1b does not increase markers of bone resorption in autosomal dominant osteopetrosis","volume":"34","author":"Imel","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116723_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10597","article-title":"Open-label pilot study of interferon Gamma\u20131b in patients with non-infantile osteopetrosis","volume":"6","author":"Nguyen","year":"2022","journal-title":"JBMR Plus."},{"key":"10.1016\/j.bone.2023.116723_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJM198407053110116","article-title":"Calcitriol for congenital osteopetrosis","volume":"311","author":"Blazar","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2023.116723_bb0070","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/BF02073378","article-title":"Failure of calcitriol treatment in a patient with malignant osteopetrosis","volume":"152","author":"van Lie Peters","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bone.2023.116723_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-3476(05)81700-7","article-title":"Malignant osteopetrosis treated with high doses of 1 alpha-hydroxyvitamin D3 and interferon gamma","volume":"123","author":"Kubo","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2023.116723_bb0080","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/jbmr.2545","article-title":"Interferon gamma, but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice","volume":"30","author":"Alam","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116723_bb0085","article-title":"Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice","volume":"36","author":"Alam","year":"2022","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bone.2023.116723_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/bloodadvances.2018025890","article-title":"Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years","volume":"3","author":"Stepensky","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.bone.2023.116723_bb0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13023-021-01955-6","article-title":"Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre","volume":"16","author":"Zhu","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2023.116723_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(05)82557-0","article-title":"Recombinant human interferon gamma therapy for osteopetrosis","volume":"121","author":"Key","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2023.116723_bb0105","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","article-title":"Long-term treatment of osteopetrosis with recombinant human interferon gamma","volume":"332","author":"Key","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2023.116723_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bone.2023.116723_bb0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI114485","article-title":"Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo","volume":"85","author":"Garrett","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2023.116723_bb0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/107999000414826","article-title":"IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production","volume":"20","author":"Madyastha","year":"2000","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.bone.2023.116723_bb0125","first-page":"384","article-title":"Combination macrophage-colony stimulating factor and interferon-gamma administration ameliorates the osteopetrotic condition in microphthalmic (mi\/mi) mice","volume":"33","author":"Rodriguiz","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2023.116723_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.21","article-title":"Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.bone.2023.116723_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2018.02.031","article-title":"RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development","volume":"110","author":"Maurizi","year":"2018","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822300056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822300056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:05:21Z","timestamp":1757613921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822300056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"alternative-id":["S875632822300056X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116723","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autosomal dominant osteopetrosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116723"}}